Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy of oral acetazolamide for decongestion in patients with heart failure. Status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Heart Failure | Phase 3 | Status: UNKNOWN